Researchers in every corner of the globe, have been working tirelessly toward a vaccine for the novel coronavirus. The scientific and medical research communities stand united in their steadfast efforts to find not just a vaccine, but other effective therapeutics such as antiviral drugs, peptide inhibitors, nucleoside analogues, and monoclonal antibodies. We have never been more honored to stand with them.
On Demand Webinar: Understanding the Enemy: An Applied Review of SARS-CoV-2 and COVID-19
As the race to overcome the COVID-19 pandemic continues, scientists working together have already made inroads not only on vaccine development efforts, but also on the ongoing impact of the novel coronavirus.
Tufts University's Graduate School of Biomedical Sciences, using BioTek (now a part of Agilent) instruments, seeks to understand the immune system response when facing a threat like the novel coronavirus.
Solutions from BioTek (a part of Agilent) can be used for COVID-19 related clinical research and assay development. Explore general virology applications, therapeutic development, cellular host response, animal models of infection, and more.
Collaborations within the greater virology community, including academic institutions, are accelerating the development of an antibody discovery program and get it into the clinic
As the response to the COVID-19 pandemic continues, officials and researchers have made a concentrated push to ramp up testing efforts. Testing not only helps inform us of the virus' prevalence but can also give us insight into how the virus has spread and whether it has accumulated potentially relevant mutations.
For Research Use Only. Not for use in diagnostic procedures.
Disclaimer: Agilent products are NOT approved for COVID-19 testing, diagnosis, treatment, or mitigation. Agilent has not validated a product to detect the novel coronavirus.